🇺🇸 FDA
Patent

US 11413296

Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

granted A61KA61K31/58A61K47/26

Quick answer

US patent 11413296 (Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract) held by The Regents of the University of California expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/58, A61K47/26, A61K47/36, A61K9/0053